I liked the price action here:
1) Increasingly large breakouts with pullbacks to prior level
2) Bullish megaphone pattern
3) Recent bullish wedge consolidation near resistance line
4) July '19 pullback consolidates atop July '17 top
BDSI sells buprenorphine formulations for pain management and opioid dependence management. Most recent quarter was a huge revenue...